Company Overview - INVO Fertility, Inc. is a healthcare services fertility company focused on expanding access to advanced treatment through the establishment, acquisition, and operation of fertility clinics [1][4] - The company will begin trading under the new Nasdaq ticker symbol "IVF" on April 28, 2025, reflecting its concentration on the fertility care market [1][3] Strategic Focus - The company has made a strategic decision to separate its fertility and oncology businesses into distinct operations, which is part of its broader strategy to enhance its focus on fertility services [2][3] - CEO Steve Shum emphasized the company's commitment to building, acquiring, and operating fertility clinics in the U.S., as well as its focus on innovative reproductive services and technologies [3] Product and Services - INVO Fertility's principal commercial strategy includes the operation of "INVO Centers" that primarily offer the intravaginal culture (IVC) procedure enabled by its proprietary INVOcell medical device [4] - The IVC procedure is designed to provide a more natural, intimate, and affordable experience compared to traditional assisted reproductive technology (ART) treatments, potentially delivering comparable results at a lower cost [4]
INVO Fertility Confirms New Nasdaq Trading Symbol of “IVF”